News
The University of Alabama at Birmingham ILD program is designated as a Pulmonary Fibrosis (PF) Foundation Care Center network site. Pulmonary fibrosis or interstitial lung diseases are chronic, ...
The placebo-controlled, double-blind ‘Wound-remodeling Hedgehog-Inhibitor ILD Study Testing Lung Function Endpoints-PF’ (WHISTLE-PF)trial outcomes for ENV-101 demonstrated statistically ...
6MWT = 6-min walk test; CTD = connective tissue disease; D LCO = diffusing capacity for carbon monoxide; ILD = interstitial lung disease. a CTD-ILD vs non-CTD forms of ILD. ESR, mm/s ...
PAH therapies improved hemodynamic parameters and reduced NT-proBNP levels in PH-ILD patients, indicating potential benefits. Precision medicine could help identify PH-ILD patients who may benefit ...
GlobalData on MSN2mon
Boehringer seeks approval of lung disease drug after second Phase III successBoehringer Ingelheim’s lung disease drug nerandomilast has been successful in a Phase III study paving the way for the company to seek approval for the asset in a second condition. Topline data ...
The University of Alabama at Birmingham ILD program is designated as a Pulmonary Fibrosis (PF) Foundation Care Center network site. Pulmonary fibrosis or interstitial lung diseases are chronic, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback